J&J acquires Neuravi to bolster neuro business
April 11, 2017Manufacturing and Production, Sales and Marketing Johnson & Johnson, Neuravi
Johnson & Johnson’s neurosurgery and neurovascular unit, Codman Neuro, has made the move to acquire Galway-based company, Neuravi. The exact …
Scotland recommends Janssen’s Imbruvica for leukaemia
April 11, 2017Manufacturing and Production, Sales and Marketing SMC, imbruvica, leukaemia
Janssen has been celebrating the news that its Imbruvica (ibrutinib) has been recommended by the Scottish Medicines Consortium (SMC) for …
Egypt and India ties in pharmaceuticals encouraged
April 11, 2017Manufacturing and Production Egypt, India, Sun Pharma
India and Egypt have been tentatively trying to build economic links for the last few years, with a particular focus …
NICE turns down BMS’ Opdivo for head and neck cancer
April 11, 2017Manufacturing and Production, Sales and Marketing BMS, NICE, opdivo
Bad news for Bristol-Myers Squibb as NICE chooses not to recommend its immunotherapy drug Opdivo (nivolumab) for use in head …
Bioverativ installs new EVP of R&D
April 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing bioverativ
Bioverativ, a biotech company that develops therapies for rare blood disorders, announced the appointment of Tim Harris as Executive Vice …
FDA approves first two antiviral hep C drugs for paediatric patients
April 10, 2017Sales and Marketing FDA, harvoni, hepatitis C, sovaldi
The FDA has given the go-ahead for two hepatitis C treatments for use in young and adolescent patients: Sovaldi (sofosbuvir) …
Virus fixes DNA mutations for possible hearing loss therapy
April 10, 2017Research and Development, Sales and Marketing Ear, deafblindness, hearing loss, inner hair
Researchers at the Medical School at Harvard and MedUni Vienna’s Department of Ear, Nose and Throat Diseases have managed to …
EMA green lights Actelion’s drug after patient deaths scare
April 10, 2017Sales and Marketing Actelion, Johnson & Johnson, Uptravi
The EMA has ruled that the five patient deaths that occurred in February of this year were not directly related …
Roche’s lung cancer drug beats Pfizer rival in study
April 10, 2017Research and Development, Sales and Marketing Alecensa, Roche
Roche has announced that its drug Alecensa (alectinib) succeeded in meeting its primary endpoint in a Phase 3 trial assessing …
Fresenius confirms takeover talks with Akorn
April 10, 2017Sales and Marketing Akorn, Fresenius
Fresenius, Europe’s largest publicly traded healthcare provider, has engaged in discussions with Akorn, a pharmaceutical generics drugmaker, with a view …
Novartis takes on dry-eye market with drug in-licensing move
April 7, 2017Medical Communications, Sales and Marketing Lubris, Novartis, dry eye
Novartis has announced that its eyecare-focused division Alcon has in-licensed dry-eye drug ECF843 from US firm Lubris for ophthalmic indications …
Old antibiotic nears new FDA approval after positive trials
April 7, 2017Medical Communications, Research and Development Pfizer, Zavante, Zolyd, antibiotic
Zavante, a biotech company based in San Diego, has unveiled positive results from a recent Phase II/III trials that could …
Top Ten most popular articles on Pharmafile.com this week
April 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday, and medical device recalls have been the flavour of the week, with both GSK and Mylan having to …
Clinical trial shows yoga negates side-effects of prostate cancer treatment
April 7, 2017Medical Communications prostate cancer, prostate treatment, yoga
Men who are treated for prostate cancer display side-effects of treatment by radiation that can often seriously disrupt their personal …
Epicast: Brain Cancer – Epidemiology Forecast to 2024
April 7, 2017Medical Communications, Research and Development brain cancer, pharmafile
Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of …
Faubel takes over RFID specialist SIL
April 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Faubel, Nachfolger
The Melsungen printer Faubel & Co. Nachfolger GmbH, which mainly produces booklet labels and custom labels for the pharmaceutical industry, …
J&J ordered to pay $5m over false marketing claims
April 6, 2017Sales and Marketing J&J, JJ, lawsuit
Johnson & Johnson has become embroiled in yet another class-action lawsuit concerning its products; this time the company is accused …
CRISPR: An up close and personal take on precision medicine
April 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRISR, Precision Medicine
Traditional approaches to patient therapies are increasingly showing their age inefficacy, but a powerful new gene editing technology is making …
Relay Therapeutics appoints Allergan CSO to CEO position
April 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Relay
Relay Therapeutics, a biotech firm launched in September 2016, has announced that Sanjiv K. Patel will be its CEO. Patel …
Takeda completes enrollment for largest-ever study of dengue vaccine
April 6, 2017Research and Development Takeda, clinical trial, dengue
Takeda announced that it had completed the enrolment for the largest clinical trial in its history, having enrolled 20,100 children …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
